DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/4xpmlq/premenstrual) has announced the addition of the "Premenstrual Dysphoric Disorder (PMDD) - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Premenstrual Dysphoric Disorder (PMDD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administ
Pherin Pharmaceuticals is a California-based drug development company that develops pherines for the treatment of neuropsychiatric and neuroendocrine conditions.